3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 2
1
Status
Unknown
30
Completed
27
Recruiting
7
Not yet recruiting
5
Active not recruiting
4
Terminated
2
Suspended
2
Withdrawn
1
Sponsor Class
OTHER
13
OTHER_GOV
2
NIH
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Conditions
Brain Neoplasms
3
Lung Neoplasms
2
Glioma
2
Breast Neoplasms
2
Skin Neoplasms
1
Obesity
1
Motor Activity
1
Malnutrition
1
Malignant Female Reproductive System Neoplasm
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Hemangioma, Capillary
1
Endometrial Neoplasms
1
Congenital Abnormalities
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Bipolar Disorder
1
Barrett Esophagus
1
Ascites
1
Arteriovenous Malformations
1
Interventions
Erlotinib Hydrochloride
1
Docetaxel
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Suspended
×
OTHER_GOV
×
Lung Neoplasms
×
Clear all
NCT01320501
2016-05-13
REALME
National Guard Health Affairs
Phase 4
Suspended
100 enrolled
NCT01356303
2016-05-13
TAXIS01
National Guard Health Affairs
Phase 2
Suspended
50 enrolled